SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: bentway4/27/2012 6:16:33 PM
  Read Replies (2) of 1582626
 
FDA OKs Viagra Rival: It Works Twice as Fast

MAKER VIVUS SAYS STENDRA PROVIDES ERECTIONS IN 15 MINUTES

By John Johnson, Newser Staff
newser.com
( But, do they last four hours? )
Posted Apr 27, 2012 2:38 PM CDT

(NEWSER) – Viagra just got some more competition: The FDA today approved the drug Stendra, which promises to provide an erection in 15 minutes, roughly twice as fast as the minimum wait time for Viagra, reports Bloomberg. Its analysts expect Vivus to pull in nearly $70 million in sales next year. By contrast, Viagra had $2 billion last year.

The drug, under the generic name avanafil, works the same as Viagra and Cialis in that it increases blood flow, notes the Wall Street Journal. Vivus has another potential winner in the blocks: It's awaiting an FDA decision on Qnexa, which would be the first anti-obesity drug on the market in 13 years.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext